Chemistry and Pharmacological Properties of Morusin and Morusinol from Morus alba: An Overview
Article Sidebar
Main Article Content
Abstract
Morusin or mulberrochromene is a prenylated flavone from the root bark of Morus alba. Structurally, the compound has three benzene rings (A–C) with one OH group at C5 of ring A, and two OH groups at C2' and C4' of ring B. There is a prenyl moiety with two methyl units at C3 of the oxygenated ring C. There is another prenyl moiety with two methyl units at C8 of ring A. Together with ring D, the 2,2-dimethyl pyran group is formed across C7 and C8. Ring D has five carbon atoms and one oxygen atom. The double bond at C2–C3 and carbonyl functional group at C4 of morusin are essential for its bioactivities. Morusinol, is another prenylated flavone with a chemical structure that is very similar to that of morusin. Exceptions are an extra OH group at C13 and a lack of the C12−C13 double bond. Morusin has been reported to exert antitumor effects on multiple types of cancer cells such as breast, liver, lung, cervical, prostate, colorectal, skin, gastric, nasopharyngeal, ovarian, pancreatic and renal cancer cells, including those of glioblastoma and osteosarcoma. The anti-cancer properties of morusinol towards melanoma and colorectal cancer cells were reported. Briefly mentioned was a case study of retraction of a paper on the selective and potent antitumor activity of morusinol towards liver carcinoma. Other pharmacological properties of morusin and morusinol were also presented. Some aspects that warrant further and more in-depth research into morusin and morusinol were suggested.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Wu Z, Zhou ZK, & Gilbert MG. Morus L. Flora China. 2003; 5:22-26.
Chan EWC, Lye PY, Wong SK. Phytochemistry, pharmacology, and clinical trials of Morus alba. Chin J Nat Med. 2016; 14(1):17-30.
Chan EWC, Wong SK, Inoue T, Chan HT. Phenolic constituents from the root bark of Morus alba with emphasis on morusin and its anti-cancer properties. J Chin Pharm Sci. 2019; 28(2):75-87.
Chan EWC, Wong SK, Tangah J, Inoue T, Chan HT. Phenolic constituents and anticancer properties of Morus alba (white mulberry) leaves. J Integr Med. 2020; 18(3):189-195.
Ercisli S, Orhan E. Chemical composition of white (Morus alba), red (Morus rubra) and black (Morus nigra) mulberry fruits. Food Chem. 2007; 103:1380−1384.
Wei H, Zhu JJ, Liu XQ, Feng WH, Wang ZM, Yan LH. Review of bioactive compounds from root barks of Morus plants (Sang-Bai-Pi) and their pharmacological effects. Cogent Chem. 2016; 2(1):1212320.
Batiha GE, Al-Snafi AE, Thuwaini MM, Teibo JO, Shaheen HM, Akomolafe AP, Teibo TK, Al-Kuraishy HM, Al-Garbeeb AI, Alexiou A, Papadakis M. Morus alba: A comprehensive phytochemical and pharmacological review. Naunyn Schmiedeberg Arch Pharmacol. 2023; 396:1399-1413.
He X, Fang J, Ruan Y, Wang X, Sun Y, Wu N, Zhao Z, Chang Y, Ning N, Guo H, Huang L. Structures, bioactivities and future prospective of polysaccharides from Morus alba (white mulberry): A review. Food Chem. 2018; 245:899-910.
Butt MS, Nazir A, Sultan MT, Schroën K. Morus alba L. nature’s functional tonic. Trends Food Sci Technol. 2008; 19(10):505-512.
Choi DW, Cho SW, Lee SG, Choi CY. The beneficial effects of morusin, an isoprene flavonoid isolated from the root bark of Morus. Int J Mol Sci. 2020; 21(18):6541.
Panek-Krzyśko A, Stompor-Gorący M. Pro-health benefits of morusin administration − An update review. Nutrients. 2021; 13(9):3043.
Hafeez A, Khan Z, Armaghan M, Khan K, Sönmez Gürer E, Abdull Razis AF, Modu B, Almarhoon ZM, Setzer WN, Sharifi-Rad J. Exploring the therapeutic and anti-tumor properties of morusin: A review of recent advances. Front Mol Biosci. 2023; 10:168298.
Zhang K, Hu X, Su J, Li D, Thakur A, Gujar V, Cui H. Gastrointestinal cancer therapeutics via triggering unfolded protein response and endoplasmic reticulum stress by 2-arylbenzofuran. Int J Mol Sci. 2024; 25(2):999.
Nomura T, Fukai T, Yamada S, Katayanagi M. Phenolic constituents of the cultivated mulberry tree (Morus alba L.). Chem Pharm Bull. 1976; 24(11):2898-2900.
Dat NT, Binh PT, van Minh C, Huong HT, Lee JJ. Cytotoxic prenylated flavonoids from Morus alba. Fitoterapia. 2010; 81(8):1224-1227.
Gupta G, Dua K, Kazmi I, Anwar F. Anticonvulsant activity of morusin isolated from Morus alba: Modulation of GABA receptor. Biomed Aging Pathol. 2014; 4(1): 29-32.
Wan LZ, Ma B, Zhang YQ. Preparation of morusin from Ramulus mori and its effects on mice with transplanted H22 hepatocarcinoma. Biofactors. 2014; 40(6):636-645.
Ma B, Cui F, Zhang Y. Rapid analysis of morusin from Ramulus mori by HPLC-DAD, its distribution in vivo and differentiation in the cultivated mulberry species. Food Nutr Sci. 2013; 4:189-194.
Vochyánová Z, Pokorná M, Rotrekl D, Smékal V, Fictum P, Suchý P, Gajdziok J, Šmejkal K, Hošek J. Prenylated flavonoid morusin protects against TNBS-induced colitis in rats. PloS One. 2017; 12(8): e0182464.
Konno C, Oshima Y, Hikino H. Morusinol, isoprenoid flavone from Morus root barks. Planta Med. 1977; 32(6):118-124.
Lee JC, Won SJ, Chao CL, Wu FL, Liu HS, Ling P, Lin CN, Su CL. Morusin induces apoptosis and suppresses NF-κB activity in human colorectal cancer HT-29 cells. Biochem Biophys Res Commun. 2008; 372:236-242.
Tseng TH, Chuang SK, Hu CC, Chang CF, Huang YC, Lin CW, Lee YJ. The synthesis of morusin as a potent antitumor agent. Tetrahedron. 2010; 66(6):1335-1340.
Lim SL, Park SY, Kang S, Park D, Kim SH, Um JY, Jang HJ, Lee JH, Jeong CH, Jang JH, Ahn KS. Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cells. Am J Cancer Res. 2015; 5(1):289-299.
Ferlinahayati, Syah YM, Juliawaty LD, Achmad SA, Hakim EH, Takayama H, Said IM, Latip J. Phenolic constituents from the wood of Morus australis with cytotoxic activity. Z Naturforsch C. 2008; 63:35-39.
Yan J, Ruan J, Huang P, Sun F, Zheng D, Zhang Y, Wang T. The structure-activity relationship review of the main bioactive constituents of Morus genus plants. J Nat Med. 2020; 74:331-340.
Agarwal S, Mohamed MS, Raveendran S, Rochani AK, Maekawa T, Kumar DS. Formulation, characterization, and evaluation of morusin-loaded niosomes for potentiation of anticancer therapy. RSC Adv. 2018; 8(57):32621-32636.
Gao L, Wang L, Sun Z, Li H, Wang Q, Yi C, Wang X. Morusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibition. Drug Design Dev Ther. 2017; 11:1789-1802.
Zhong ZH, Zhang YQ. Inhibition of morusin from mulberry branches as an agro-waste to MDA-MB-453 and HCT116 cancer cells by inducing cell apoptosis and disturbing the cell cycle. Res Square. https://doi.org/10.21203/rs.3.rs-205057/v1
Lin WL, Lai DY, Lee YJ, Chen NF, Tseng TH. Antitumor progression potential of morusin suppressing STAT3 and NF-κB in human hepatoma SK-Hep1 cells. Toxicol Lett. 2015; 232(2):490-498.
Ding B, Lv Y, Zhang YQ. Anti-tumor effect of morusin from the branch bark of cultivated mulberry in Bel-7402 cells via the MAPK pathway. RSC Adv. 2016; 6(21): 17396-17404.
Cho AR, Park WY, Lee HJ, Sim DY, Im E, Park JE, Ahn CH, Shim BS, Kim SH. Antitumor effect of morusin via G1 arrest and anti-glycolysis by AMPK activation in hepatocellular cancer. Int J Mol Sci. 2021; 22(19):10619.
Li H, Wang Q, Dong L, Liu C, Sun Z, Gao L, Wang X. Morusin suppresses breast cancer cell growth in vitro and in vivo through C/EBPβ and PPARγ mediated lipo-apoptosis. J Exp Clin Cancer Res. 2015; 34:137-149.
Kang S, Kim EO, Kim SH, Lee JH, Ahn KS, Yun M, Lee SG. Morusin induces apoptosis by regulating expression of Bax and Survivin in human breast cancer cells. Oncol Lett. 2017; 13(6):4558-4562.
Li H, Xiao J, Li X, Huang Q, Liu Q, Zhang Q. Mechanism of morusin on breast cancer via network pharmacology and in vitro experiments. Medicine. 2023; 102(28): e34300.
Sarmoko S, Pratama AH, Choironi NA, Fareza MS. Bioinformatic study of the active compound of morusin in mulberry (Morus alba) against breast cancer. Indones J Cancer Chemoprev. 2023;14(1):60-71.
Park HJ, Min TR, Chi GY, Choi YH, Park SH. Induction of apoptosis by morusin in human non-small cell lung cancer cells by suppression of EGFR/STAT3 activation. Biochem Biophys Res Commun. 2018; 505(1):194-200.
Yin XL, Lv Y, Wang S, Zhang YQ. Morusin suppresses A549 cell migration and induces cell apoptosis by downregulating the expression of COX2 and VEGF genes. Oncol Rep. 2018; 40(1):504-510.
Park HJ, Park SH. Induction of cytoprotective autophagy by morusin via AMP-activated protein kinase activation in human non-small cell lung cancer cells. Nutr Res Pract. 2020; 14(5): 478-489.
Wang J, Liu X, Zheng H, Liu Q, Zhang H, Wang X, Shen T, Wang S, Ren D. Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells. Chem-Biol Interact. 2020; 331:109279.
Wang L, Guo H, Yang L, Dong L, Lin C, Zhang J, Lin P, Wang X. Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction. Mol Cell Biochem. 2013; 379:7-18.
Cho SW, Na W, Choi M, Kang SJ, Lee SG, Choi CY. Autophagy inhibits cell death induced by the anti-cancer drug morusin. Am J Cancer Res. 2017; 7(3):518-530.
Park YJ, Choi DW, Cho SW, Han J, Yang S, Choi CY. Stress granule formation attenuates RACK1-mediated apoptotic cell death induced by morusin. Int J Mol Sci. 2020; 21(15):5360.
Koo JI, Sim DY, Lee HJ, Ahn CH, Park J, Park SY, Lee D, Shim BS, Kim B, Kim SH. Apoptotic and anti‐Warburg effect of morusin via ROS mediated inhibition of FOXM1/c‐Myc signaling in prostate cancer cells. Phytother Res. 2023; 37: 4473-4487.
Wu HE, Su CC, Wang SC, Liu PL, Cheng WC, Yeh HC, Chuu CP, Chen JK, Bao BY, Lee CH, Ke CC. Anticancer effects of morusin in prostate cancer via inhibition of Akt/mTOR signaling pathway. Am J Chin Med. 2023; 51(4):1019-1039.
Guo H, Liu C, Yang L, Dong L, Wang L, Wang Q, Li H, Zhang J, Lin P, Wang X. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte trans-differentiation, and apoptosis induction. Mol Carcinogen. 2016; 55(1):77-89.
Park D, Ha IJ, Park SY, Choi M, Lim SL, Kim SH, Lee JH, Ahn KS, Yun M, Lee SG. Morusin induces TRAIL sensitization by regulating EGFR and DR5 in human glioblastoma cells. J Nat Prod. 2016; 79(2):317-323.
Agarwal S, Mohamed MS, Mizuki T, Maekawa T, Kumar DS. Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy. J Mater Chem B. 2019; 7(39): 5896-5919.
Zhao Y, Zhou X, Hong L, Yao J, Pan J, Shafi S, Siraj S, Ahmad N, Liu J, Zhao R, Sun M. Morusin regulates the migration of M2 macrophages and GBM cells through the CCL4-CCR5 axis. Int Immunopharmacol. 2025; 147:113915.
Lee JC, Won SJ, Chao CL, Wu FL, Liu HS, Ling P, Lin CN, Su CL. Morusin induces apoptosis and suppresses NF-κB activity in human colorectal cancer HT-29 cells. Biochem Biophys Res Commun. 2008; 372(1):236-242.
Park WY, Lee HJ, Sim DY, Im E, Park JE, Ahn CH, Shim BS, Kim SH. miR193a-5p mediated ZNF746 and c-Myc signaling axis is critically involved in morusin-induced apoptosis in colorectal cancer cells. Cells. 2021; 10(8):2065.
Zhou Y, Li X, Ye M. Morusin inhibits the growth of human colorectal cancer HCT116derived sphereforming cells via the inactivation of Akt pathway. Int J Mol Med. 2021; 47(4):51-61
Zhao K, Dai Q, Wu J, Wei Z, Duan Y, Chen B. Morusin enhances the antitumor activity of MAPK pathway inhibitors in BRAF-mutant melanoma by inhibiting the feedback activation of STAT3. Eur J Cancer. 2022; 165:58-70.
Liu W, Ji Y, Wang F, Li C, Shi S, Liu R, Li Q, Guo L, Liu Y, Cui H. Morusin shows potent antitumor activity for melanoma through apoptosis induction and proliferation inhibition. BMC Cancer. 2023; 23(1):602-618.
Wang F, Zhang D, Mao J, Ke XX, Zhang R, Yin C, Gao N, Cui H. Morusin inhibits cell proliferation and tumor growth by down-regulating c-Myc in human gastric cancer. Oncotarget. 2017; 8(34):57187.
Chen M, Xiao S, Sun P, Li Y, Xu Z, Wang J. Morusin suppresses the stemness characteristics of gastric cancer cells induced by hypoxic micro environment through inhibition of HIF-1α accumulation. Toxicon. 2024; 241:107675.
Huang CC, Wang PH, Lu YT, Yang JS, Yang SF, Ho YT, Lin CW, Hsin CH. Morusin suppresses cancer cell invasion and MMP-2 expression through ERK signaling in human nasopharyngeal carcinoma. Molecules. 2020; 25(20):4851.
Xue J, Li R, Zhao X, Ma C, Lv X, Liu L, Liu P. Morusin induces paraptosis-like cell death through mitochondrial calcium overload and dysfunction in epithelial ovarian cancer. Chem Biol Interact. 2018; 283:59-74.
Kim C, Kim JH, Oh EY, Nam D, Lee SG, Lee J, Kim SH, Shim BS, Ahn KS. Blockage of STAT3 signaling pathway by morusin induces apoptosis and inhibits invasion in human pancreatic tumor cells. Pancreas. 2016; 45(3):409-419.
Yang C, Luo J, Luo X, Jia W, Fang Z, Yi S, Li L. Morusin exerts anti-cancer activity in renal cell carcinoma by disturbing MAPK signaling pathways. Ann Translat Med. 2020; 8(6): 327-340
Zhang Y, Weng Q, Chen J, Han J. Morusin inhibits human osteosarcoma via the PI3K-Akt signaling pathway. Curr Pharm Biotechnol. 2020; 21(13):1402-1409.
Ji L, Chai Y, Tong C, Hu Y, Li J, Lu B, Yu J. Morusin reverses epithelial-mesenchymal transition in gallbladder cancer cells by regulating STAT3/HIF-1α signaling. Chem Biol Drug Des. 2025; 105(1):e70054.
Zelová H, Hanáková Z, Čermáková Z, Šmejkal K, Dalĺ Acqua S, Babula P, Cvačka J, Hošek J. Evaluation of anti-inflammatory activity of prenylated substances isolated from Morus alba and Morus nigra. J Nat Prod. 2014; 77(6):1297-1303.
Guo L, Dong Z, Zhang X, Yang Y, Hu X, Ji Y, Li C, Wan S, Xu J, Liu C, Zhang Y. Morusinol extracted from Morus alba induces cell cycle arrest and apoptosis via inhibition of DNA damage response in melanoma by CHK1 degradation through the ubiquitin-proteasome pathway. Phytomedicine. 2023; 114: 154765.
Zhang X, Dong Z, Yang Y, Liu C, Li J, Sun W, Zhu Y, Shen Y, Wang Z, Lü M, Cui H. Morusinol extracted from Morus alba inhibits cell proliferation and induces autophagy via FOXO3a nuclear accumulation-mediated cholesterol biosynthesis obstruction in colorectal cancer. J Agric Food Chem. 2023; 71(43):16016-16031.
Zhu Z, Xiao T, Chang X, Hua Y, Gao J. RETRACTED: Morusinol exhibits selective and potent antitumor activity against human liver carcinoma by inducing autophagy, G2/M cell cycle arrest, inhibition of cell invasion and migration, and targeting of Ras/MEK/Erk pathway. Med Sci Monit. 2019; 25: 1864.
Zhu Z, Xiao T, Chang X, Hua Y, Gao J. RETRACTED: Morusinol exhibits selective and potent antitumor activity against human liver carcinoma by inducing autophagy, G2/M cell cycle arrest, inhibition of cell invasion and migration, and targeting of Ras/MEK/Erk pathway. Med Sci Monit. 2021; 27: e932335-1.
De Souza MM, Bittar M, Cechinel-Filho V, Yunes RA, Messana I, Delle Monache FD, Ferrari F. Antinociceptive properties of morusin, a prenylflavonoid isolated from Morus nigra root bark. Z Naturforsch C. 2000; 55:256-260.
Jia Y, He W, Zhang H, He L, Wang Y, Zhang T, Peng J, Sun P, Qian Y. Morusin ameliorates IL-1β-induced chondrocyte inflammation and osteoarthritis via NF-κB signal pathway. Drug Design, Dev Ther. 2020; 14:1227-1240.
Hsu JH, Yang CS, Chen JJ. Antioxidant, anti-α-glucosidase, anti-tyrosinase, and anti-inflammatory activities of bioactive components from Morus alba. Antioxidants. 2022; 11(11): 2222.
Pang D, Liao S, Wang W, Mu L, Li E, Shen W, Liu F, Zuo Y. Destruction of the cell membrane and inhibition of cell phosphatidic acid biosynthesis in Staphylococcus aureus: An explanation for the antibacterial mechanism of morusin. Food Funct. 2019; 10(10):6438-6446.
Wu SC, Han F, Song MR, Chen S, Li Q, Zhang Q, Zhu K, Shen JZ. Natural flavones from Morus alba against methicillin-resistant Staphylococcus aureus via targeting the proton motive force and membrane permeability. J Agric Food Chem. 2019; 67(36): 10222-10234.
Shi-De L, Nemec J, Ning BM. Anti-HIV flavonoids from Morus alba. Acta Bot Yunnan. 1995; 17:89-95.
Lv Q, Lin J, Wu X, Pu H, Guan Y, Xiao P, He C, Jiang B. Novel active compounds and the anti-diabetic mechanism of mulberry leaves. Front Pharmacol. 2022; 13:986931.
Lee HJ, Lyu DH, Koo U, Nam KW, Hong SS, Kim KO, Kim KH, Lee D, Mar W. Protection of prenylated flavonoids from Mori Cortex Radicis (Moraceae) against nitric oxide-induced cell death in neuroblastoma SH-SY5Y cells. Arch Pharm Res. 2012; 35:163-170.
Gupta G, Chellappan DK, Agarwal M, Ashwathanarayana M, Nammi S, Pabreja K, Dua K. Pharmacological evaluation of the recuperative effect of morusin against aluminum trichloride (AlCl3)-induced memory impairment in rats. Cent Nerv Syst Agents. 2017; 17(3):196-200.
Yang ZG, Matsuzaki K, Takamatsu S, Kitanaka S. Inhibitory effects of constituents from Morus alba var. multicaulis on differentiation of 3T3-L1 cells and nitric oxide production in RAW264.7 cells. Molecules. 2011; 16(7):6010.
Ko HH, Wang JJ, Lin HC, Wang JP, Lin CN. Chemistry and biological activities of constituents from Morus australis. Biochim Biophys Acta − Gen Subj. 1999; 1428: 293-299.
Fukai T, Satoh K, Nomura T, Sakagami H. Anti-nephritis and radical scavenging activity of prenylflavonoids. Fitoterapia. 2003; 74:720-724.
Chen C, Wang J, Chen J, Zhou L, Wang H, Chen J, Xu Z, Zhu S, Liu W, Yu R, Lu J. Morusin alleviates mycoplasma pneumonia via the inhibition of Wnt/β-catenin and NF-κB signaling. Biosci Rep. 2019; 39(6):20190190.
Xu P, Chen Q, Chen X, Qi H, Yang Y, Li W, Yang X, Gunawan A, Chen S, Zhang H, Shen HM. Morusin and mulberrin extend the lifespans of yeast and C. elegans via suppressing nutrient-sensing pathways. GeroScience. 2023; 45(2):949-964.
Jin C, Zheng J, Yang Q, Jia Y, Li H, Liu X, Xu Y, Chen Z, He L. Morusin inhibits RANKL-induced osteoclastogenesis and ovariectomized osteoporosis. Comb Chem High Throughput Screen. 2023; 27(9):1358-1370.
Chang J, Zou S, Xu S, Xiao Y, Zhu D. Screening of inhibitors against idiopathic pulmonary fibrosis: Few-shot machine learning and molecule docking based drug repurposing. Curr Comput Aided Drug Des. 2024; 20(2):134-144.
Yildirim K, Bozkurt S, Basibuyuk HH, Coban AY. Anti-tuberculosis activity of morusin: a promising flavonoid from white mulberry. Int J Tuberc Lung Dis. 2024; 28(1):37-41.
Jia Q, Lv Y, Miao C, Feng J, Ding Y, Zhou T, Han S, He L. A new MAS-related G protein-coupled receptor X2 cell membrane chromatography analysis model based on HALO-tag technology and its applications. Talanta. 2024; 268:125317.
Zhang YL, Luo JG, Wan CX, Zhou ZB, Kong LY. Four new flavonoids with α‐glucosidase inhibitory activities from Morus alba var. tatarica. Chem Biodivers. 2015; 12(11):1768-1776.
Kim JY, Lee WS, Kim YS, Curtis-Long MJ, Lee BW, Ryu YB, Park KH. Isolation of cholinesterase-inhibiting flavonoids from Morus lhou. J Agric Food Chem. 2011; 59(9): 4589-4596.
Guo YQ, Tang GH, Lou LL, Li W, Zhang B, Liu B, Yin S. Prenylated flavonoids as potent phosphodiesterase-4 inhibitors from Morus alba: Isolation, modification, and structure-activity relationship study. Eur J Med Chem. 2018; 144:758-766.
Lee JJ, Yang H, Yoo YM, Hong SS, Lee D, Lee HJ, Lee HJ, Myung CS, Choi KC, Jeung EB. Morusinol extracted from Morus alba inhibits arterial thrombosis and modulates platelet activation for the treatment of cardiovascular disease. J Atheroscler Thromb. 2012; 19(6):516-522.
Kwon HW. Pharmacological actions of morusinol on modulation of platelet functions via integrin αIIb/β signaling. J Appl Biol Chem. 2023; 66:171-178.
Zuo GY, Yang CX, Han J, Li YQ, Wang GC. Synergism of prenylflavonoids from Morus alba root bark against clinical MRSA isolates. Phytomedicine. 2018; 39:93-99.
Čulenová M, Sychrová A, Hassan ST, Berchová-Bímová K, Svobodová P, Helclová A, Michnová H, Hošek J, Vasilev H, Suchý P, Kuzminová G. Multiple in vitro biological effects of phenolic compounds from Morus alba root bark. J Ethno-pharmacol. 2020; 248:112296.
Qin J, Fan M, He J, Wu XD, Peng LY, Su J, Cheng X, Li Y, Kong LM, Li RT, Zhao QS. New cytotoxic and anti-inflammatory compounds isolated from Morus alba L. Nat Prod Res. 2015; 29(18):1711-1718.